Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group (Q59647360)
Jump to navigation
Jump to search
article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group |
article |
Statements
Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group (English)
J Latreille
J Pater
D Johnston
F Laberge
D Stewart
J Rusthoven
P Hoskins
B Findlay
E McMurtrie
L Yelle
C Williams
D Walde
S Ernst
H Dhaliwal
D Warr
F Shepherd
D Mee
L Nishimura